780201C
Avanti
18:1 PE MCC
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[4-(p-maleimidomethyl)cyclohexane-carboxamide] (sodium salt), chloroform
同義詞:
1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine-N-[4-(p-maleimidomethyl)cyclohexane-carboxamide] (sodium salt)
登入查看組織和合約定價
全部照片(1)
About This Item
推薦產品
化驗
>99% (TLC)
形狀
liquid
包裝
pkg of 1 × 2.5 mL (780201C-25mg)
製造商/商標名
Avanti Polar Lipids 780201C
濃度
10 mg/mL (780201C-25mg)
運輸包裝
dry ice
儲存溫度
−20°C
一般說明
18:1 PE MCC (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[4-(p-maleimidomethyl)cyclohexane-carboxamide]) lipid comprising of phosphoethanolamine linked to two oleic acid via its phosphate group and to a maleimide group via its amino group. It is a maleimide-functionalized thiol-reactive lipid.
應用
18:1 PE MCC 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[4-(p-maleimidomethyl)cyclohexane-carboxamide] has been used:
- in liposome preparation for cysteine coupling studies
- in nanodisc impregnation for ras sarcoma protein (K-RAS4B) tethering
- in liposome preparation for single molecule imaging
包裝
5 mL Clear Glass Sealed Ampule (780201C-25mg)
法律資訊
Avanti Research is a trademark of Avanti Polar Lipids, LLC
訊號詞
Danger
危險分類
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
標靶器官
Central nervous system
儲存類別代碼
6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
水污染物質分類(WGK)
WGK 3
閃點(°F)
does not flash
閃點(°C)
does not flash
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。
Liposome-based assays to study membrane-associated protein networks
Methods in Enzymology, 534, 223-243 (2014)
The Journal of cell biology, 216(10), 3051-3060 (2017-09-09)
Bicaudal D2 (BICD2) joins dynein with dynactin into a ternary complex (termed DDB) capable of processive movement. Point mutations in the BICD2 gene have been identified in patients with a dominant form of spinal muscular atrophy, but how these mutations
Cell chemical biology, 25(11), 1327-1336 (2018-08-21)
KRAS is frequently mutated in several of the most lethal types of cancer; however, the KRAS protein has proven a challenging drug target. K-RAS4B must be localized to the plasma membrane by prenylation to activate oncogenic signaling, thus we endeavored
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務